Next Article in Journal
Avoiding the Interference of Doxorubicin with MTT Measurements on the MCF-7 Breast Cancer Cell Line
Next Article in Special Issue
Accelerating the Production of Druggable Targets: Eukaryotic Cell-Free Systems Come into Focus
Previous Article in Journal
A Loose Parts Randomized Controlled Trial to Promote Active Outdoor Play in Preschool-aged Children: Physical Literacy in the Early Years (PLEY) Project
Previous Article in Special Issue
A User’s Guide to Cell-Free Protein Synthesis
Open AccessBenchmark

Optimizing Cell-Free Protein Synthesis for Increased Yield and Activity of Colicins

1
Department of Chemical and Biological Engineering, Illinois Institute of Technology, Chicago, IL 60616, USA
2
Department of Chemical and Biological Engineering, Northwestern University, Evanston, IL 60208, USA
*
Author to whom correspondence should be addressed.
Methods Protoc. 2019, 2(2), 28; https://doi.org/10.3390/mps2020028
Received: 23 February 2019 / Revised: 2 April 2019 / Accepted: 3 April 2019 / Published: 11 April 2019
(This article belongs to the Special Issue Cell-Free Synthetic Biology)
Colicins are antimicrobial proteins produced by Escherichia coli that hold great promise as viable complements or alternatives to antibiotics. Cell-free protein synthesis (CFPS) is a useful production platform for toxic proteins because it eliminates the need to maintain cell viability, a common problem in cell-based production. Previously, we demonstrated that colicins produced by CFPS based on crude Escherichia coli lysates are effective in eradicating antibiotic-tolerant bacteria known as persisters. However, we also found that some colicins have poor solubility or low cell-killing activity. In this study, we improved the solubility of colicin M from 16% to nearly 100% by producing it in chaperone-enriched E. coli extracts, resulting in enhanced cell-killing activity. We also improved the cytotoxicity of colicin E3 by adding or co-expressing the E3 immunity protein during the CFPS reaction, suggesting that the E3 immunity protein enhances colicin E3 activity in addition to protecting the host strain. Finally, we confirmed our previous finding that active colicins can be rapidly synthesized by observing colicin E1 production over time in CFPS. Within three hours of CFPS incubation, colicin E1 reached its maximum production yield and maintained high cytotoxicity during longer incubations up to 20 h. Taken together, our findings indicate that colicin production can be easily optimized for improved solubility and activity using the CFPS platform. View Full-Text
Keywords: colicins; cell-free protein synthesis; antimicrobials; chaperones colicins; cell-free protein synthesis; antimicrobials; chaperones
Show Figures

Figure 1

MDPI and ACS Style

Jin, X.; Kightlinger, W.; Hong, S.H. Optimizing Cell-Free Protein Synthesis for Increased Yield and Activity of Colicins. Methods Protoc. 2019, 2, 28.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop